INVO Bioscience reduces warrant exercise price from $2.85 to $1.20 per share

INVO Fertility, Inc.

Effective April 17, 2024, warrant exercise price cut to $1.20 from $2.85 per share.
Amendment to Warrant Agency Agreement allows future adjustments to lower exercise price.
Warrants for 3,160,000 shares were issued in August 2023 public offering.
Company may adjust exercise price lower without holder consent under amended terms.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. amended Amendment to the Warrant Agent Agreement with Transfer Online, Inc. (effective 2024-04-17).

Action: amendment
Counterparty: Transfer Online, Inc.
Effective: 2024-04-17

Exact text from the filing

On April 17, 2024, the Company and the Warrant Agent entered into an Amendment to the Warrant Agent Agreement (the “Amendment”) to confirm that the Company may adjust the exercise price of the of the Warrants to provide an exercise price per share that is lower than the then-current exercise price of the Warrants.

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-015013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.